The ALK mutation in NSCLC stands for:

Prepare for the CMID Test. Study with flashcards and multiple choice questions, each question contains hints and explanations. Get ready for your exam with confidence!

Multiple Choice

The ALK mutation in NSCLC stands for:

Explanation:
The main idea is the exact name behind the acronym ALK. It stands for Anaplastic lymphoma kinase, a receptor tyrosine kinase that was first described in association with anaplastic large cell lymphoma. In NSCLC, rearrangements involving this gene produce a constantly active kinase that helps drive cancer growth, which is why ALK inhibitors are an important targeted therapy. The other possible expansions don’t match the established gene name—leukemia, lymphoid, or adenosine kinase refer to different proteins or contexts.

The main idea is the exact name behind the acronym ALK. It stands for Anaplastic lymphoma kinase, a receptor tyrosine kinase that was first described in association with anaplastic large cell lymphoma. In NSCLC, rearrangements involving this gene produce a constantly active kinase that helps drive cancer growth, which is why ALK inhibitors are an important targeted therapy. The other possible expansions don’t match the established gene name—leukemia, lymphoid, or adenosine kinase refer to different proteins or contexts.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy